Literature DB >> 15198126

Intercellular adhesion molecule-1 and blood-spinal cord barrier disruption in central nervous system radiation injury.

Robert A Nordal1, C Shun Wong.   

Abstract

Central nervous system (CNS) injury is a major dose-limiting toxicity that limits the effectiveness of radiation therapy. Blood-brain barrier (BBB) disruption and white matter necrosis are prominent features. Increased expression of intercellular adhesion molecule-1 (ICAM-1) accompanies and is believed to be important in BBB disruption in other CNS injuries. Our aim was to assess the expression of ICAM-1 and its relationship to regions of blood-spinal cord barrier (BSCB) disruption in the irradiated rat spinal cord. ICAM-1 protein was detected by immunohistochemistry and quantified by digital image analysis. Cells expressing ICAM-1 were identified. BSCB disruption was assessed by immunohistochemical detection of serum albumin. ICAM-1 expression localized predominantly to vascular endothelium and increased in white matter but not in grey matter at 24 hours and 17 to 20 weeks after 22 Gy. A dose response was observed from 16 to 20 Gy. ICAM-1 expression colocalized with regions of BSCB disruption. ICAM-1 expression was also observed in glia, a majority of which were astrocytes. The parallel dose response, time course, and spatial distribution of ICAM-1 expression and albumin leakage suggest a role for ICAM-1 in late BSCB disruption after radiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198126     DOI: 10.1093/jnen/63.5.474

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  13 in total

1.  Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortex.

Authors:  Jose Javier Miguel-Hidalgo; Sorcha Nithuairisg; Craig Stockmeier; Grazyna Rajkowska
Journal:  Brain Behav Immun       Date:  2006-07-07       Impact factor: 7.217

2.  Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus.

Authors:  Linnea R Freeman; Vivian Haley-Zitlin; Cheryl Stevens; Ann-Charlotte Granholm
Journal:  Nutr Neurosci       Date:  2011-01       Impact factor: 4.994

Review 3.  Pathobiology of radiation myelopathy and strategies to mitigate injury.

Authors:  C S Wong; M G Fehlings; A Sahgal
Journal:  Spinal Cord       Date:  2015-03-24       Impact factor: 2.772

4.  Mitigating effect of biotin against irradiation-induced cerebral cortical and hippocampal damage in the rat brain tissue.

Authors:  Nadia Abdel-Magied; Shereen M Shedid; Amal G Ahmed
Journal:  Environ Sci Pollut Res Int       Date:  2019-03-25       Impact factor: 4.223

Review 5.  Clinical biomarkers of angiogenesis inhibition.

Authors:  Aaron P Brown; Deborah E Citrin; Kevin A Camphausen
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

6.  Vascular Endothelial Growth Factor Enhanced the Angiogenesis Response of Human Umbilical Cord-Derived Mesenchymal Stromal Cells in a Rat Model of Radiation Myelopathy.

Authors:  Hua You; Li Wei; Jing Zhang; Jia-Ning Wang
Journal:  Neurochem Res       Date:  2015-08-02       Impact factor: 3.996

7.  Demyelination Occurred as the Secondary Damage Following Diffuse Axonal Loss in a Rat Model of Radiation Myelopathy.

Authors:  Li Wei; Yong Zhou; Chang-Jiang Liu; Ke Zheng; Hua You
Journal:  Neurochem Res       Date:  2016-12-08       Impact factor: 3.996

8.  Gamma-ray irradiation stimulates the expression of caveolin-1 and GFAP in rat spinal cord: a study of immunoblot and immunohistochemistry.

Authors:  Meejung Ahn; Heechul Kim; Jeong Tae Kim; Jeeyoung Lee; Jin Won Hyun; Jae Woo Park; Taekyun Shin
Journal:  J Vet Sci       Date:  2006-12       Impact factor: 1.672

Review 9.  Clinical Perspectives in Brain Metastasis.

Authors:  Krutika Deshpande; Ian Buchanan; Vahan Martirosian; Josh Neman
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

Review 10.  Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain.

Authors:  Shin-Ichi Miyatake; Noasuke Nonoguchi; Motomasa Furuse; Erina Yoritsune; Tomo Miyata; Shinji Kawabata; Toshihiko Kuroiwa
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.